Hospital Billing Fraud: What the Capstone Case Reveals

Hospital billing fraud and laboratory billing fraud share common patterns — unauthorized physician credentials, medically unnecessary testing, and compensation arrangements tied to referral volume. A recent federal civil complaint and parallel criminal indictment arising from the Medicare billing practices of Atlanta-based Capstone Diagnostics, LLC illustrate how those patterns can develop inside a clinical laboratory or diagnostic operation, and what employees who recognize them may be able to do under the False Claims Act.

The Capstone Diagnostics matter, filed in the U.S. District Court for the Northern District of Georgia, offers a detailed picture of the conduct the government alleges — and of how a former laboratory manager’s decision to come forward as a whistleblower set the case in motion. Understanding the alleged schemes can help employees in labs, hospital outpatient departments, and diagnostic operations recognize conduct that may be worth reporting.

The Capstone Diagnostics Case: What the Government Alleges

Who Was Involved and What Was Alleged

According to the DOJ’s September 17, 2026 announcement, the United States filed a False Claims Act complaint against Jay Johnson, the former Chief Operating Officer and Chief Executive Officer of Capstone Diagnostics, LLC, and Austin Whiles, Capstone’s former Chief Sales Officer and Vice President of Business Development, along with associated entities. The complaint alleges that the defendants caused Medicare to pay approximately $13.7 million for genetic and respiratory pathogen panel testing that was not medically necessary. The case is captioned United States ex rel. Allen v. Capstone Diagnostics, LLC, et al., Civil Action No. 1:19-CV-5598-SEG. Every False Claims Act matter is different; results depend on the specific facts of each case, and no similar outcome is implied.

Two Alleged Schemes

The complaint describes two distinct alleged schemes operating between 2019 and 2021. In the first, Johnson and Whiles allegedly targeted church-sponsored health fairs and religious conferences, directing Capstone personnel to swab attendees en masse and then — without permission — using physicians’ names, signatures, standing orders, and other paperwork to make the testing appear properly ordered and medically necessary. In the second, they allegedly added medically unnecessary respiratory pathogen panels to COVID-19 tests sought by senior living communities, inflating Medicare reimbursements by improperly using community- and chain-wide standing orders, copying physician signatures, standardizing diagnosis codes, having sales personnel enter orders rather than treating providers, and paying unlawful remuneration alleged to violate the Anti-Kickback Statute. Johnson allegedly transferred millions of dollars derived from the schemes to his now-former wife, Sarah Haslock, and Whiles allegedly secretly routed to himself approximately $4.75 million in volume-based commissions from independent marketers.

Settlements and Criminal Charges

The United States reached civil settlements with Capstone and its owner Andrew Maloney for $14.3 million, and with Capstone’s billing company VitalAxis, Inc. for $300,479, to resolve their potential civil liability under the False Claims Act. On December 10, 2025, a federal grand jury indicted Johnson on charges including conspiracy to commit health care and wire fraud, health care fraud, wire fraud, conspiracy to receive and pay kickbacks, and payment of kickbacks in connection with a federal health care program. Those charges are currently pending. “Johnson and Whiles allegedly took advantage of individuals at religious events and senior living facilities to line their pockets and drain millions of dollars from the Medicare trust fund,” said U.S. Attorney Theodore S. Hertzberg. Every False Claims Act matter is different; results depend on the specific facts of each case, and no similar outcome is implied.

Five Hospital and Lab Billing Fraud Patterns Employees May Recognize

The conduct alleged in the Capstone complaint reflects patterns that employees inside clinical laboratories, hospital outpatient departments, and diagnostic operations may encounter. Employees who observe these patterns may want to learn more about how the False Claims Act applies to hospital and laboratory billing fraud before deciding whether to come forward.

Unauthorized Use of Physician Credentials

The Capstone complaint alleges that physician names, signatures, and standing orders were used without the treating provider’s actual authorization to make testing appear properly ordered. Billing or clinical staff who observe orders being entered, signed, or modified without provider involvement may be witnessing conduct relevant to a False Claims Act claim. This pattern can appear in hospital outpatient settings as readily as in freestanding laboratories.

Medically Unnecessary Add-On Testing

The complaint alleges that respiratory pathogen panels were routinely added to COVID-19 tests regardless of individual patient need, inflating Medicare reimbursements paid to Capstone. Employees in order-entry, coding, or laboratory operations who see systematic add-ons driven by revenue rather than clinical indication may be in a position to report such conduct. The key indicator is whether testing decisions are made on a patient-by-patient clinical basis or applied uniformly across a population.

Standardized Diagnosis Codes Applied Across Patients

The Capstone complaint specifically references the use of standardized diagnosis codes as a mechanism to make non-individualized testing appear medically necessary. Coders, billers, or compliance personnel who observe blanket diagnosis code assignment — rather than codes reflecting each patient’s actual clinical presentation — may be observing a billing irregularity. When the same diagnosis code appears on claims for an entire senior living community or conference group, that uniformity may signal a problem.

Sales Personnel Entering Clinical Orders

The complaint alleges that sales personnel, rather than treating providers, entered orders for the respiratory pathogen panels billed to Medicare. Anyone in a clinical or administrative role who observes non-clinical personnel initiating or modifying orders for billable services may be seeing conduct that could be relevant to a fraud investigation. Treating providers — not sales staff — are generally responsible for determining what testing a patient needs.

Volume-Based Compensation Tied to Referrals

The complaint alleges that Whiles secretly routed to himself approximately $4.75 million in volume-based commissions from independent marketers, and that unlawful remuneration was paid in violation of the Anti-Kickback Statute. Employees aware of compensation arrangements tied to testing volume or referral counts may have information relevant to an Anti-Kickback Statute or False Claims Act matter. The combination of volume-based pay and Medicare billing is a pattern that enforcement activity has repeatedly targeted. Every False Claims Act matter is different; results depend on the specific facts of each case, and no similar outcome is implied.

What the False Claims Act Provides for Whistleblowers

The False Claims Act’s qui tam provisions allow a private citizen to play a central role in cases like Capstone’s. Under 31 U.S.C. § 3730(b), a person may bring a civil action for a violation of section 3729 for the person and for the United States Government. The complaint is filed under seal while the government investigates. In the Capstone matter, the United States intervened on September 4, 2026, in a lawsuit filed by Jesse Allen, the former laboratory manager for Capstone, who is identified as the whistleblower who filed the initial lawsuit.

Under 31 U.S.C. § 3730(d)(1), when the government proceeds with an action, the person who brought the suit shall receive at least 15 percent but not more than 25 percent of the proceeds of the action or settlement, depending on the extent to which the person substantially contributed to the prosecution of the action — subject to the proviso in that subsection that limits the share to no more than 10 percent where the action is based primarily on disclosures of specific information relating to allegations or transactions in a criminal, civil, or administrative hearing, a congressional, administrative, or Government Accounting Office report, hearing, audit, or investigation, or from the news media. Under 31 U.S.C. § 3731, the limitations period for a False Claims Act civil action may extend up to ten years in certain circumstances, which means that employees who observed conduct some time ago may still have the ability to come forward.

If practices like these look familiar from your own workplace, you can discuss what you have seen with a Price Armstrong attorney confidentially and at no cost. Call (888) 670-9542 or use the secure evaluation form below.

Frequently Asked Questions About Hospital Billing Fraud Whistleblower Cases

What is hospital billing fraud under the False Claims Act?

Under 31 U.S.C. § 3729, the False Claims Act imposes liability on any person who knowingly presents, or causes to be presented, a false or fraudulent claim for payment or approval to the United States. In the hospital and laboratory billing context, this can include claims for testing that was not medically necessary, claims supported by unauthorized physician signatures, or claims inflated through add-on tests not ordered by a treating provider — all patterns alleged in the Capstone Diagnostics complaint.

Who can file a qui tam lawsuit for hospital billing fraud?

Under 31 U.S.C. § 3730(b), a person may bring a civil action for a violation of section 3729 for the person and for the United States Government. The Capstone matter illustrates that a former laboratory manager — an insider with direct knowledge of billing and operational practices — may be well positioned to file such a complaint. The complaint is filed under seal, and the government then investigates before deciding whether to intervene.

Does a whistleblower have to still be employed to file a False Claims Act complaint?

The False Claims Act’s text does not require that a relator be currently employed at the time of filing. Jesse Allen, the whistleblower in the Capstone matter, is described as a former laboratory manager for Capstone. The limitations period under 31 U.S.C. § 3731 may extend up to ten years in certain circumstances, which means that individuals who observed potential fraud during prior employment may still have the ability to bring a claim. An attorney who handles False Claims Act matters can evaluate the specific facts and timing of any potential case.